J. Dworschak

Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid

D. Zillikens, C. Probst, W. Schlumberger, 2015, Archives of Dermatological Research.

Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides.

D. Zillikens, O. Kreuzer, R. Ludwig, 2012, Journal of dermatological science.

Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins

D. Zillikens, C. Probst, J. Westermann, 2014, Experimental dermatology.

Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice

D. Zillikens, C. Probst, E. Schmidt, 2018, Front. Immunol..

Pathogenicity of Autoantibodies in Anti-p200 Pemphigoid

D. Zillikens, T. Hashimoto, M. Hirose, 2012, PloS one.

Bullous pemphigoid induced by IgG targeting type XVII collagen non‐NC16A/NC15A extracellular domains is driven by Fc gamma receptor‐ and complement‐mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade

P. Verheesen, C. Probst, K. Vanderheyden, 2023, The Journal of pathology.